Not getting enough ZZZs or going to bed late into the night can have an adverse impact on your health and well being. Here’s ...

William Blair lowered their Q3 2025 EPS estimates for ResMed in a research report issued on Monday, February 3rd. William Blair analyst M. Andrew now anticipates that the medical equipment provider ...

Artificial intelligence startups Truefoundry and Cognida.ai have bagged investments in separate Series A funding rounds ...

Worried there are no great-value ASX shares left to buy? Our Foolish writers reckon these five are worth a good look!

ResMed Inc. (NYSE:RMD – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fifteen ratings firms that are covering the firm, Marketbeat.com reports. One research ...

An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) is now available. ResMed Inc has ...

Unlike the majority of ASX 200 income stocks, ResMed pays dividends every quarter. The post Looking to bag the record high ...

The recipe to most happy investing outcomes is painfully simple. But if it were that easy, wouldn't everybody do it?

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Index rose 3.20% in January as markets had a strong start to 2025 with the benchmark S&P/ASX 200 rising by 5% to reach a new ...

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also ...